As of May 2024 MiMedx Group has a market cap of $1.08 Billion. This makes MiMedx Group the world's 5032th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.08 B | -15.26% |
2023 | $1.28 B | 306.25% |
2022 | $0.31 B | -53.35% |
2021 | $0.67 B | -32.82% |
2020 | $1.00 B | 20.1% |
2019 | $0.83 B | 322.39% |
2018 | $0.19 B | -85.8% |
2017 | $1.40 B | 44.3% |
2016 | $0.97 B | -3.55% |
2015 | $1.00 B | -19.06% |
2014 | $1.24 B | 36.24% |
2013 | $0.91 B | 168.82% |
2012 | $0.33 B | 304.42% |
2011 | $83.91 M | -3.38% |
2010 | $86.84 M | 137.93% |
2009 | $36.5 M | -78.04% |
2008 | $0.16 B |
On May 4th, 2024 the market cap of MiMedx Group was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Medtronic MDT | $108.46 B | 9,871.09% | ๐ฎ๐ช Ireland |
Teleflex TFX | $9.56 B | 778.99% | ๐บ๐ธ USA |
Steris STE | $20.53 B | 1,787.73% | ๐ฎ๐ช Ireland |
NuVasive NUVA | $2.08 B | 91.65% | ๐บ๐ธ USA |
Hill-Rom HRC | $10.30 B | 846.94% | ๐บ๐ธ USA |
CryoLife CRY | $0.70 B | -35.36% | ๐บ๐ธ USA |